• Citer

Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer

par Piccart-Gebhart, Martine ;Cardoso, Fatima ;Atalay, G
Référence European journal of cancer, 38, 6, page (S52-S54)
Publication Publié, 2002-11

Article révisé par les pairs

• Détails

Titre:	Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer
Auteur:	Piccart-Gebhart, Martine; Cardoso, Fatima; Atalay, G
Informations sur la publication:	European journal of cancer, 38, 6, page (S52-S54)
Statut de publication:	Publié, 2002-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antineoplastic Agents -- therapeutic use
	Antineoplastic Agents, Hormonal -- therapeutic use
	Breast Neoplasms -- drug therapy
	Cross-Over Studies
	Double-Blind Method
	Enzyme Inhibitors -- therapeutic use
	Female
	Humans
	Neoplasm Metastasis
	Nitriles -- therapeutic use
	Progestins -- therapeutic use
	Randomized Controlled Trials as Topic
	Tamoxifen -- therapeutic use
	Treatment Outcome
	Triazoles -- therapeutic use
Note générale:	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/s0959-8049(02)00285-x
	info:pii/S095980490200285X
	info:scp/0036754206
	info:pmid/12409074